4.7 Article

Arachidonic acid release mediated by OX1 orexin receptors

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 159, 期 1, 页码 212-221

出版社

WILEY
DOI: 10.1111/j.1476-5381.2009.00535.x

关键词

orexin; hypocretin; OX1 receptor; phospholipase A(2); arachidonic acid; PLA(2); iPLA(2); cPLA(2); Ca2+ influx

资金

  1. Academy of Finland
  2. Sigrid Juselius Foundation
  3. Magnus Ehrnrooth Foundation
  4. University of Helsinki
  5. Novo Nordisk Foundation
  6. Swedish Research Council
  7. Uppsala University

向作者/读者索取更多资源

Background and purpose: We have previously shown that lipid mediators, produced by phospholipase D and C, are generated in OX1 orexin receptor signalling with high potency, and presumably mediate some of the physiological responses to orexin. In this study, we investigated whether the ubiquitous phospholipase A(2) (PLA(2)) signalling system is also involved in orexin receptor signalling. Experimental approach: Recombinant Chinese hamster ovary-K1 cells, expressing human OX1 receptors, were used as a model system. Arachidonic acid (AA) release was measured from H-3-AA-labelled cells. Ca2+ signalling was assessed using single-cell imaging. Key results: Orexins strongly stimulated [H-3]-AA release (maximally 4.4-fold). Orexin-A was somewhat more potent than orexin-B (pEC(50) = 8.90 and 8.38 respectively). The concentration-response curves appeared biphasic. The release was fully inhibited by the potent cPLA(2) and iPLA(2) inhibitor, methyl arachidonyl fluorophosphonate, whereas the iPLA(2) inhibitors, R- and S-bromoenol lactone, caused only a partial inhibition. The response was also fully dependent on Ca2+ influx, and the inhibitor studies suggested involvement of the receptor-operated influx pathway. The receptor-operated pathway, on the other hand, was partially dependent on PLA(2) activity. The extracellular signal-regulated kinase, but not protein kinase C, were involved in the PLA(2) activation at low orexin concentrations. Conclusions and implications: Activation of OX1 orexin receptors induced a strong, high-potency AA release, possibly via multiple PLA(2) species, and this response may be important for the receptor-operated Ca2+ influx. The response coincided with other high-potency lipid messenger responses, and may interact with these signals. British Journal of Pharmacology (2010) 159, 212-221; doi:10.1111/j.1476-5381.2009.00535.x; published online 4 December 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Azulene-based compounds for targeting orexin receptors

Teppo O. Leino, Ainoleena Turku, Jari Yli-Kauhaluoma, Jyrki P. Kukkonen, Henri Xhaard, Erik A. A. Wallen

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Letter Endocrinology & Metabolism

BAT is independently affected by peripheral and central pathways

J. P. Kukkonen

INTERNATIONAL JOURNAL OF OBESITY (2018)

Article Pharmacology & Pharmacy

Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26

Maiju K. Rinne, Teppo O. Leino, Ainoleena Turku, Pauli M. Turunen, Yana Steynen, Henri Xhaard, Erik A. A. Wallen, Jyrki P. Kukkonen

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

Article Chemistry, Medicinal

Structure-Activity Relationships of 1-Benzoylazulenes at the OX1 and OX2 Orexin Receptors

Ainoleena Turku, Teppo O. Leino, Lasse Karhu, Jari Yli-Kauhaluoma, Jyrki P. Kukkonen, Erik A. A. Wallen, Henri Xhaard

CHEMMEDCHEM (2019)

Article Plant Sciences

CRK2 Enhances Salt Tolerance by Regulating Callose Deposition in Connection with PLDα1

Kern Hunter, Sachie Kimura, Anne Rokka, Huy Cuong Tran, Masatsugu Toyota, Jyrki P. Kukkonen, Michael Wrzaczek

PLANT PHYSIOLOGY (2019)

Article Pharmacology & Pharmacy

Allosteric interactions via the orthosteric ligand binding sites in a constitutive G-protein-coupled receptor homodimer

Jyrki P. Kukkonen

Summary: Recent data indicates cooperative effects between identical orthosteric binding sites in a G-protein-coupled receptor dimer. A mathematical model was created to test this concept, showing that even a neutral receptor ligand can allosterically affect agonist binding through the orthosteric binding site.

PHARMACOLOGICAL RESEARCH (2021)

Article Medical Laboratory Technology

Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassays

Mikael Lindstrom, Mink Schinkelshoek, Pentti J. Tienari, Jyrki P. Kukkonen, Risto Renkonen, Rolf Fronczek, Gert Jan Lammers, Outi Itkonen

Summary: A liquid chromatography mass spectrometry assay (LC-MS/MS) was developed for the quantification of CSF orexin-A and B, revealing lower concentrations of orexin-A in narcolepsy type 1 patients compared to controls. Commercial radioimmunoassay (RIA) yielded higher concentrations than LC-MS/MS.

CLINICAL BIOCHEMISTRY (2021)

Article Pharmacology & Pharmacy

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors

Stephen P. H. Alexander, Arthur Christopoulos, Anthony P. Davenport, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F. Armstrong, Elena Faccenda, Simon D. Harding, Adam J. Pawson, Christopher Southan, Jamie A. Davies, Maria Pia Abbracchio, Wayne Alexander, Khaled Al-hosaini, Magnus Baeck, Nicholas M. Barnes, Ross Bathgate, Jean-Martin Beaulieu, Kenneth E. Bernstein, Bernhard Bettler, Nigel J. M. Birdsall, Victoria Blaho, Francois Boulay, Corinne Bousquet, Hans Braeuner-Osborne, Geoffrey Burnstock, Girolamo Calo, Justo P. Castano, KevinJ Catt, Stefania Ceruti, Paul Chazot, Nan Chiang, Bice Chini, Jerold Chun, Antonia Cianciulli, Olivier Civelli, Lucie H. Clapp, Rejean Couture, Zsolt Csaba, Claes Dahlgren, Gordon Dent, Khuraijam Dhanachandra Singh, Steven D. Douglas, Pascal Dournaud, Satoru Eguchi, Emanuel Escher, Edward J. Filardo, Tung Fong, Marta Fumagalli, Raul R. Gainetdinov, Marc de Gasparo, Craig Gerard, Marvin Gershengorn, Fernand Gobeil, Theodore L. Goodfriend, Cyril Goudet, Karen J. Gregory, Andrew L. Gundlach, Joerg Hamann, Julien Hanson, Richard L. Hauger, Debbie L. Hay, Akos Heinemann, Morley D. Hollenberg, Nicholas D. Holliday, Mastgugu Horiuchi, Daniel Hoyer, Laszlo Hunyady, Ahsan Husain, Adriaan P. IJzerman, Tadashi Inagami, Kenneth A. Jacobson, Robert T. Jensen, Ralf Jockers, Deepa Jonnalagadda, Sadashiva Karnik, Klemens Kaupmann, Jacqueline Kemp, Charles Kennedy, Yasuyuki Kihara, Takio Kitazawa, Pawel Kozielewicz, Hans-Juergen Kreienkamp, Jyrki P. Kukkonen, Tobias Langenhan, Katie Leach, Davide Lecca, John D. Lee, Susan E. Leeman, Jerome Leprince, Xaria X. Li, Tom Lloyd Williams, Stephen J. Lolait, Amelie Lupp, Robyn Macrae, Janet Maguire, Jean Mazella, Craig A. McArdle, Shlomo Melmed, Martin C. Michel, Laurence J. Miller, Vincenzo Mitolo, Bernard Mouillac, Christa E. Mueller, Philip Murphy, Jean-Louis Nahon, Tony Ngo, Xavier Norel, Duuamene Nyimanu, Anne-Marie Ocarroll, Stefan Offermanns, Maria Antonietta Panaro, Marc Parmentier, Roger G. Pertwee, Jean-Philippe Pin, Eric R. Prossnitz, Mark Quinn, Rithwik Ramachandran, Manisha Ray, Rainer K. Reinscheid, Philippe Rondard, G. Enrico Rovati, Chiara Ruzza, Gareth J. Sanger, Torsten Schoeneberg, Gunnar Schulte, Stefan Schulz, Deborah L. Segaloff, Charles N. Serhan, Leigh A. Stoddart, Yukihiko Sugimoto, Roger Summers, Valerie P. Tan, David Thal, Walter (Wally) Thomas, PieterB M. W. M. Timmermans, Kalyan Tirupula, Giovanni Tulipano, Hamiyet Unal, Thomas Unger, Celine Valant, Patrick Vanderheyden, David Vaudry, Hubert Vaudry, Jean-Pierre Vilardaga, Christopher S. Walker, Ji Ming Wang, Donald T. Ward, Hans-Juergen Wester, Gary B. Willars, Trent M. Woodruff, Chengcan Yao, Richard D. Ye

Summary: The Concise Guide to PHARMACOLOGY 2021/22 presents concise overviews of nearly 1900 human drug targets with an emphasis on selective pharmacology, along with links to a more detailed knowledgebase. It serves as a permanent, citable record for researchers, providing useful information in the field of pharmacology.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists

Teppo O. Leino, Ainoleena Turku, Lauri Urvas, Karuna Adhikari, Jouni Oksanen, Yana Steynen, Jari Yli-Kauhaluoma, Henri Xhaard, Jyrki P. Kukkonen, Erik A. A. Wallen

Summary: The rare ring structure Azulene was investigated as a possible biphenyl mimetic for the orexin receptor agonist Nag 26. The most potent compound based on Azulene was identified as an OX1 orexin receptor agonist, but the spatial shape and electron distribution of the Azulene ring and biphenyl scaffold are not identical, suggesting different binding modes in the binding site for their derivatives.

BIOORGANIC & MEDICINAL CHEMISTRY (2023)

Letter Multidisciplinary Sciences

The G protein preference of orexin receptors is currently an unresolved issue

Jyrki P. Kukkonen

NATURE COMMUNICATIONS (2023)

Letter Clinical Neurology

Measurement of orexin levels is currently an uncertain business

Jyrki P. Kukkonen

SLEEP MEDICINE (2023)

Article Neurosciences

Cellular Signaling Mechanisms of Hypocretin/Orexin

Jyrki P. Kukkonen, Pauli M. Turunen

Summary: Orexin receptors (OXRs) are promiscuous G-protein-coupled receptors that signal via multiple pathways, potentially forming complexes with other receptors to regulate signal transduction. In neurons, OXR activation leads to inhibition of K+ channels and activation of Na+/Ca2+ exchangers and nonselective cation channels, with the exact intracellular signaling pathways to downstream targets remaining unclear. OXR signaling is complex and can vary based on cell type and environment.

OREXIN SYSTEM: Basic Science and Role in Sleep Pathology (2021)

Article Immunology

No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children

Krister Melen, Pinja Jalkanen, Jyrki P. Kukkonen, Markku Partinen, Hanna Nohynek, Arja Vuorela, Outi Vaarala, Tobias L. Freitag, Seppo Meri, Ilkka Julkunen

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2020)

Article Medicine, Research & Experimental

Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells

Jinar Rostami, Maria Jantti, Hengjing Cui, Maiju K. Rinne, Jyrki P. Kukkonen, Anna Falk, Anna Erlandsson, Timo Myohanen

BIOMEDICINE & PHARMACOTHERAPY (2020)

Meeting Abstract Chemistry, Multidisciplinary

Azulene-based compounds targeting orexin receptors

Teppo Leino, Ainoleena Turku, Jari Yli-Kauhaluoma, Jyrki Kukkonen, Henri Xhaard, Erik Wallen

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2019)

暂无数据